Breast Cancer Research Foundation   Report issue

Foundation Phase 1 Phase 2 Phase 3
Founded: New York NY United States (1993)

Organization Overview

First Clinical Trial
2003
NCT00336791
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Breast Cancer Research Foundation